EUVIMEDEUVIMED entdecken
Leserbrief

Letter: Does Serum HBV RNA Add Incremental Value for Hepatocellular Carcinoma Risk Stratification Beyond Established Predictors?

Yuanyan Sun, Yonggang Dai iD

Alimentary Pharmacology & Therapeutics · 2026-06 · 63 (12) · 1699-1700

DOI: 10.1111/apt.70708 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Alimentary Pharmacology & Therapeutics, online erschienen am 04.05.2026. Verfasst von Yuanyan Sun und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, Shandong Provincial Third Hospital, Shandong University, Jinan City, Shandong Province, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 5 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Clinical Laboratory, Shandong Provincial Third Hospital, Shandong University, Jinan City, Shandong Province, China.

ORCID-Profile: Yonggang Dai

Zitieren

APA

Sun, Y., & Dai, Y. (2026). Letter: Does Serum HBV RNA Add Incremental Value for Hepatocellular Carcinoma Risk Stratification Beyond Established Predictors?. Alimentary Pharmacology & Therapeutics, 63(12), 1699-1700. https://doi.org/10.1111/apt.70708

Vancouver

Sun Y, Dai Y. Letter: Does Serum HBV RNA Add Incremental Value for Hepatocellular Carcinoma Risk Stratification Beyond Established Predictors?. Alimentary Pharmacology & Therapeutics. 2026;63(12):1699-1700. doi:10.1111/apt.70708

BibTeX
@article{Sun2026,
  author = {Sun, Yuanyan and Dai, Yonggang},
  title = {Letter: Does Serum HBV RNA Add Incremental Value for Hepatocellular Carcinoma Risk Stratification Beyond Established Predictors?},
  journal = {Alimentary Pharmacology & Therapeutics},
  year = {2026},
  volume = {63},
  number = {12},
  pages = {1699--1700},
  doi = {10.1111/apt.70708}
}
Kostenlos starten →